Administration of resveratrol to prevent or treat restenosis fol

Details Administration of resveratrol to prevent or treat restenosis fol Administration of resveratrol to prevent or treat restenosis fol

1998-05-13

2000-02-08

Jones, Dwayne C.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

C-o-group doai

514734, A01N 3108

Patent

active

060229012

ABSTRACT:
A method for preventing or treating restenosis and for preventing the recurrence or progression of coronary heart disease is provided. The method involves administration of a selected active agent to a patient following coronary intervention, e.g., coronary artery bypass surgery, endarterectomy, heart transplantation, heart balloon angioplasty, atherectomy, laser ablation or endovascular stenting. The active agent comprises cis-resveratrol, trans-resveratrol, a mixture thereof, or a pharmacologically acceptable salt, ester, amide, prodrug or analog thereof. Administration may be oral, parenteral, or the like. Pharmaceutical compositions for use in conjunction with the therapeutic method are also provided.

REFERENCES:
Goldberg et al., "Method to assay the Concentrations of Phenolic Constituents of Biological Interest in Wines", Anal. Chem. 68:1688-1694, 1996.
Pace-Asciak et al., "The Red Wine Phenolics Trans-Resveratrol and Quercetin Block Human Platelet Aggregation and Eicosanoik Synthesis: Implications for Protection Against Coronary Heart Disease," Clinica Chimica Acta 235:207-219, 1995.
Tardif et al., "Probucol and Multivitamins in the Prevention of Restenosis After Coronary Angioplasty", The New Eng. J. Medicine 337:365-419, Aug. 1997.
Bertelli et al. (1995) "Antiplatelet Activity of Synthetic and Natural Resveratrol in Red Wine," Inst. J. Tiss. Reac. XVII(1):1-3.
Frankel et al. (1993) "Inhibition of Human LDL Oxidation by Resveratrol," The Lancet 341:1104.
Goldberg et al. (1994) "Direct Injection Gas Chromatographic Mass Spectrometric Assay for trans-Resveratrol," Anal. Chem. 66:3959-3963.
Goldberg et al. (1995) "A Global Survey of Trans-Resveratrol Concentrations in Commercial Wines," Am. J. Enol. Vitic. 46(2):159-165.
Jang et al. (1997) "Cancer Chemopreventive Activity of Resveratrol, a Natural Product Derived from Grapes," Science 275:218-220.
Jeandet et al. (1991) "The Production of Resveratrol (3,5,4'-trihydroxystilbene) by Grape Berries in Different Developmental Stages," Am. J. Enol. Vitic. 42 (1):41-46.
Lee et al. (1994), Society for Neuroscience Abstracts 20(1-2):1648.
Moreno-Manas et al. (1985) "Dehydroacetic Acid Chemistry, A New Synthesis of Resveratrole, A Phytoalexine of Vitis Vinifera," Anal. Quim 81:157-61.
Soleas et al. (1995) "A Derivatized Gas Chromatographic-Mass Spectrometric Method for the Analysis of Both Isomers of Resveratrol in Juice and Wine," Am. J. Enol. Vitic. 46(3):346-352.

Affiliated with

Also associated with

Rating

Administration of resveratrol to prevent or treat restenosis fol does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Administration of resveratrol to prevent or treat restenosis fol, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Administration of resveratrol to prevent or treat restenosis fol will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1681778